| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,505 |
4,562 |
$217K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,088 |
2,417 |
$161K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,911 |
1,570 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,399 |
1,945 |
$40K |
| 99215 |
Prolong outpt/office vis |
332 |
263 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
188 |
163 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,520 |
1,311 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
781 |
579 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
165 |
96 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
104 |
94 |
$4K |
| 87428 |
|
12 |
12 |
$398.10 |
| 36415 |
Collection of venous blood by venipuncture |
196 |
175 |
$205.98 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
113 |
90 |
$78.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
212 |
173 |
$39.40 |
| 81002 |
|
19 |
12 |
$30.60 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
329 |
294 |
$0.00 |